Lv51
1508 积分 2024-11-01 加入
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
17天前
已完结
From KRASG12D to Pan-KRAS InhibitorsA Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
1个月前
已关闭
Assessing the Risk of Salt Disproportionation Using Crystal Structure and Surface Topography Analysis
1个月前
已完结
Translational modelling to predict human pharmacokinetics and pharmacodynamics of a Bruton's tyrosine kinase‐targeted protein degrader BGB‐16673
1个月前
已完结
Toward a Telescoped Batch-Continuous Process for the KRAS G12C Inhibitor GH35: Controlling a Critical Dimeric Impurity during Acryloylation
1个月前
已完结
β-glucuronidase-triggered ortho-hydroxyl-mediated cyclization strategy for the efficient delivery of phenolic payloads in antibody-drug conjugates
1个月前
已关闭
An alternative synthesis for Exatecan mesylate
1个月前
已完结
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer
1个月前
已完结
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
1个月前
已完结
Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs
1个月前
已完结
皖公网安备34019202002308
